U.S. federal trademark · Serial No. 87821911 · Reg. No. 5875067
House mark used for drug delivery agents consisting of polymer compounds that facilitate the delivery of pharmaceuticals for the treatment of diseases and conditions, including ocular diseases, namely, uveitis, retinal vein occlusion, macular edema, macular disease, retinal disease
House mark for sustained drug delivery systems for pharmaceuticals
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.